Enzychem Lifesciences Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ki-Young Sohn
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 5.1% |
| Management average tenure | no data |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Enzychem Lifesciences (KOSDAQ:183490) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 13
There's Reason For Concern Over Enzychem Lifesciences Corporation's (KOSDAQ:183490) Price
Aug 13Rock star Growth Puts Enzychem Lifesciences (KOSDAQ:183490) In A Position To Use Debt
May 09If You Had Bought Enzychem Lifesciences (KOSDAQ:183490) Shares A Year Ago You'd Have Earned 43% Returns
Feb 17
CEO
Ki-Young Sohn
no data
Tenure
Ki-Young Sohn serves as the Chairman and Chief Executive Officer at Enzychem Lifesciences Corporation. Ki-Young Sohn holds MBA from graduate School of Business, Dept. of Business Administration Korea Unive...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Chief Executive Officer | no data | no data | 5.1% ₩ 5.2b | |
| Member of Corporate Advisory Committee & CTO | 2.8yrs | no data | no data | |
| Chief Scientific Officer & Member of the Board of Directors | no data | no data | no data | |
| CMO & Director | 7.7yrs | no data | no data | |
| Executive Director | no data | no data | no data | |
| VP & Executive Director | no data | no data | no data | |
| Director | 7.7yrs | no data | no data | |
| Vice Chairman | no data | no data | 0.080% ₩ 82.2m | |
| Director | 7.7yrs | no data | no data | |
| Director | 7.7yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data |
7.7yrs
Average Tenure
71yo
Average Age
Experienced Board: A183490's board of directors are considered experienced (7.7 years average tenure).